Kineta Inc.
Kineta Inc.
Kineta Inc.
Close
  • about
    • company
    • team
    • board
    • SAB
  • pipeline
    • overview
    • KVA12123 (VISTA)
    • CD27
  • partnerships
  • investors
    • overview
    • press releases
    • events & presentations
    • stock information
    • analyst coverage
    • SEC filings
    • corporate governance
    • IRS Form 8937
  • careers
  • contact
  • en_USEnglish
    • ko_KRKorean
  • about
    • company
    • team
    • board
    • SAB
  • pipeline
    • overview
    • KVA12123 (VISTA)
    • CD27
  • partnerships
  • investors
    • overview
    • press releases
    • events & presentations
    • stock information
    • analyst coverage
    • SEC filings
    • corporate governance
    • IRS Form 8937
  • careers
  • contact
  • en_USEnglish
    • ko_KRKorean

[be_recent_posts_author_no_link title=”Latest News from Kineta” category_id=”4,3″ num_posts=”6″ post_offset=”0″ num_words_limit=”0″ show_date_author=”1″ show_more_link=”0″ more_link_text=”Read more” show_thumbs=”0″ remove_thumb_frame=”0″ thumb_frame_shadow=”0″ default_thumb=”0″ post_thumb_width=”100″ post_thumb_height=”80″]

Recent Kineta News

  • VISTA a Potential New Immuno-Oncology Target in Acute Myeloid Leukemia | Blood | American Society of Hematology (ashpublications.org)
  • Kineta to Host KOL Event to Review New Data from VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors on December 5, 2023
  • Kineta to Present at the 5th Annual Macrophage-Directed Therapies Summit
  • Kineta Unveils Positive New Data from VISTA-101 Clinical Trial of KVA12123 at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
  • Kineta Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Post placeholder image
February 21, 2017 in Biotech Industry News

Snail venom compound ‘offers chronic pain therapy

Kineta Inc 2 Like Post Comments Off on Snail venom compound ‘offers chronic pain therapy
Read More
Post placeholder image
August 5, 2016 in Biotech Industry News

As millions visit Rio Olympics, a lack of funding leaves Zika researchers in the dark, GeekWire

Kineta Inc 2 Like Post Comments Off on As millions visit Rio Olympics, a lack of funding leaves Zika researchers in the dark, GeekWire
Read More
Post placeholder image
May 11, 2016 in Biotech Industry News

Kineta wins $7.2M award to develop antiviral drug focused on Lassa fever, GeekWire

Kineta Inc 2 Like Post Comments Off on Kineta wins $7.2M award to develop antiviral drug focused on Lassa fever, GeekWire
Read More
Post placeholder image
May 5, 2016 in Biotech Industry News

Seattle biotech Kineta wins $7.2M award for drug development, Puget Sound Business Journal

Kineta Inc 2 Like Post Comments Off on Seattle biotech Kineta wins $7.2M award for drug development, Puget Sound Business Journal
Read More
Prev1…456Next

219 Terry Ave. N. Suite 300. Seattle, WA 98109

Sign Up for Email Alerts

219 Terry Ave. N. Suite 300. Seattle, WA 98109

  • about
  • pipeline
  • partnerships
  • investors
  • contact
Sign Up for Email Alerts

© 2023 Kineta Inc.        Privacy Policy       Terms of Use

English
English
Korean